SlideShare ist ein Scribd-Unternehmen logo
1 von 29
Department of Cardiology, Luhe hospital,Capital 
Medical University 
Jincheng Guo 
AimRADIAL 2014 1
Disclosure 
• Research grant 
The capital health research and 
development of special 
2011-7071-01 
AimRADIAL 2014 2
Background 
15 45 75 105 135 165 195 225 
15 
12 
9 
6 
3 
0 
Mortality (%) 
Door to balloon time (minutes) 
BMJ 2009;338:b1807 AimRADIAL 2014 3
Background 
• Several strategies to improve D2B times prior to 
catheterization laboratory (cath lab) arrival. 
• Few recommendations in the cath lab, cath lab to 
balloon(C2B) times. 
• Transradial vs transfemoral improved clinical outcomes. 
• longer C2B times and fluoroscopic times for transradial 
approach 
AimRADIAL 2014 4
Background 
Trasnradial Strategies For Primary PCI In Cathlab 
patients with STEMI 
Radial access 
NIRA NIRA 
Primary PCI 
IRA 
GC? 
GC 
IRA 
Diganostic MP 
JL/R 
NIRA+IRA 
IRA:infarct-related artery; NIRA:non-infarct-related artery; 
GC: guiding catheter L: JL R: JR MP: multipurpose 
ECG-Guided CA 
5 
AimRADIAL 2014
What is the optimal guiding catheter for “a 
single catheter technique” 
Author year Journal Guiding cather study Sample 
Youssef 
AA, et al 
2008 Eurointervention Ikari left (IL) 3.5 Prospective 
observational 
621 
Roberts 
EB, et al 
2011 J Interv Cardiol Q guide atheter observational 57 
Chow J, 
et al 
2012 J Interv Cardiol Ikari left retrospective 
study 
362 
Moon KW, 
et al 
2012 J Interv Cardiol 6 Fr RM® 3.5 retrospective 
study 
31 
Malaiapan 
Y , et al 
2013 Cardiovasc 
Revasc Med 
Kimny matched 
cohort 
106 
AimRADIAL 2014 
6
What is the ideal single guide catheter? 
Q Curve Ikari left (IL) kimny 
AimRADIAL 2014 
7
What is the ideal single guide catheter for 
us? 
MAC guide catheter 
AimRADIAL 2014 8
MAC3.5 guiding catheter for LCA 
AimRADIAL 2014 9
Manipulation of the MAC guiding catheter for LCA 
Natural position U shape curve 
Push/ Counterclockwise pull 
clockwise 
AimRADIAL 2014 
10
Manipulation of the MAC guiding catheter for RCA 
clockwise Push and U shape form Engage and pull 
AimRADIAL 2014 
11
To investigate the safety and feasibilityof using a 
single guiding catheter (MAC 3.5) for left and right 
coronary angiography and intervention in patients 
with STEMI 
Objective 
AimRADIAL 2014 12
Inclusion Criteria 
• symptom onset within 12 hours before admission 
• candidate for primary PCI 
• no contraindications to antiplatelet and anticoagulant therapy 
• lesions of native coronary artery. 
Exclusion Criteria 
No radial pulse palpable 
Throm bolytic therapy 
AimRADIAL 2014 
13
Definitions of times and intervals 
Time/interval Source/Definition 
Cathlab arrival time Time that the patient was placed on the cathlab table 
Prepare time Time from cath lab table to local anesthesia 
Cannulation time time from local anesthesia to sheath insertion 
Coronary time time from sheath insertion to first cineangiography recording 
Time/Definitions interval of times and intervals 
Source/Definition 
Cathlab Cath lab=Catheterization arrival time lab, CA=coronary Time that angiography; the patient PCI=was percutaneous placed on the coronary cathlab intervention 
table 
Prepare time Time from cath lab table to local anesthesia 
Cannulation time time from local anesthesia to sheath insertion 
Coronary time time from sheath insertion to first cineangiography recording 
Diagnostic time first cineangiography recording to completion of the last angiographic 
Diagnostic time first cineangiography recording to completion of the last angiographic cine 
acquisition 
procedure time,CA Cannulation time+ coronary time+ diagnostic time 
cine acquisition 
procedure time,PCI Time from the end of diagnostic time to the end of PCI 
procedure time,CA Cannulation time+ coronary time+ diagnostic time 
procedure time,PCI Time from the end of diagnostic time to the end of PCI 
Total procedure time Including CA and PCI procedure time 
Cath lab door to balloon 
time(C2B) 
Total procedure time Including CA and PCI procedure time 
Interval between the Cath lab arrival time and the first device was activated to 
open the artery regardless of the type of device used. 
Interval between the Cath lab arrival time and the first device was 
activated to open the artery regardless of the type of device used. 
Cath lab door to balloon 
time(C2B) 
Door to balloon time(D2B) Interval from initial presentation to cathlab arrive time+C2B 
Door to balloon time(D2B) Interval from initial presentation to cathlab arrive time+C2B 
Cath lab=Catheterization lab, CA=coronary angiography; PCI=percutaneous 
coronary intervention 
AimRADIAL 2014 
14
Design 
• DESIGN: 
Prospective, randomized (1:1), 
parallel group, Single-center 
trial. 
MAC group—MAC for left and right 
Coronary angiography an 
intervention 
Control group--first underwent 
coronary angiography with 
diagnostic Tiger catheter followed 
by guiding catheter selection for 
intervention 
360 patients enrolled between September 
2011 and Dec 2013 in our center 
MAC group 
(N=180) 
Control Group 
(N=180) 
Crossover 
to Femoral 
6 9 
MAC group 
(N=180) 
Control Group 
(N=180) 
cathlab door to balloon time 
Procedure time, fluoroscopic time,Door 
to balloon time, MACE at 2 years 
Intention-to-treat analysis 
AimRADIAL 2014 
15
Primay PCI protocol 
access 
sheath 
Coronary 
angiogarphy 
Right raidal 
Catheter 
Tiger 
MAC3.5 
NIRA 
IRA 
RCA 2 projections 
LCA 5 projections 
RCA 1 projections 
LCA 
LAO+cranial 
Cranial+caudal 
LAO45 
AP cra+cau 
Wire 
Hytrophilic Long 
Long Hytrophilic 
2 projections 
anticoagulation heparin 
AimRADIAL 2014 
16
Table 1 baseline characteristics 
MAC group(n=180) Control group(n=180) p value 
age 63.23±12.07 62.47±12.25 0.702 
male/female 135/45 136/44 0.903 
Cardiovascular risk factors 
diabetes mellitus, n(%) 50(27.8) 56(31.1) 0.488 
hypertension, n(%) 74(41.1) 68(37.8) 0.458 
hypercholesterolaemia, n(%) 61(33.9) 56(31.3) 0.574 
Present smoking, n(%) 106(58.9) 96(53.3) 0.288 
history of CAD, n(%) 18 (10.0) 26(14.4) 0.198 
history of stroke, n(%) 19 (10.6) 23(12.8) 0.511 
Previous MI, n(%) 5(2.8) 5(2.8) 1.000 
Previous renal insufficiency, n(%) 5(2.8) 6(3.3) 0.752 
Previous PCI, n(%) 11(6.1) 9(5.0) 0.636 
Killip class on admission, n(%) 0.410 
I~ II 165(91.7) 161(89.4) 
III~ IV 15(8.03 19(10.6) 
AimRADIAL 2014 
17
Coronary angiography success rate 
MAC 3.5 
LCA(180) 
RCA(180) 
Failure(6) 
success(174) 
Failure(1) 
success(179) 
success(1) 
Tiger 
LCA(180) 
RCA(180) 
Failure(4) 
success(176) 
Failure(3) 
success(177) 
Tiger 
JL4.0 
success(5) 
= 
= 
Tiger/AL2.0 
JL4.0/4.5 
MAC3.5 GC 
JL4.0 
success(1) 
success(1) 
success(2) 
= 
= 
= 
AL1.0 
JR4.0 
success(1) 
success(1) 
success(1) 
= 
= 
= 
= success(1) 
SAL1.0 JR3.5 
GC 
AimRADIAL 2014 
18
Table 2 Angiographic and procedural characteristics(1) 
MAC group 
(n=180) 
Control group 
(n=180) 
p value 
Target vessel, n(%) 0.070 
Left main 1(0.6) 0(0) 
LAD 76(42.2) 97(53.9) 
LCX 26(14.4) 15(8.3) 
RCA 77(42.8) 68(37.8) 
Disease vessles,n(%) 
0.270 
single 59(32.8) 73(40.6) 
double 63(35.0) 52(28.9) 
triple 58(32.2) 55(30.6) 
AimRADIAL 2014 19
Table 2 Angiographic and procedural characteristics(2) 
MAC group(n=180) Control group(n=180) p value 
Access site crossover 6(3.3) 9(5.0) 0.428 
Guiding catheter exchange 13(9.72) 19(9.86) 0.266 
Pre-PCI TIMI flow, n(%) 0.354 
0/1 146(81.1) 151(83.9) 
2 10(5.6) 13(7.2) 
3 24(13.3) 16(8.9) 
Post-PCI TIMI flow, n(%) 0.704 
0/1 8(4.4) 9(5.0) 
2 15(8.3) 11(6.1) 
3 157(87.2) 160(88.9) 
CTFC ,frames 
Pre-PCI 89.4±23.3 90.5±22.3 0.548 
Post-PCI 31.6±20.9 30.2±21.5 0.518 
AimRADIAL 2014 
20
Table 2 Angiographic and procedural characteristics(2) 
MAC group(n=180) Control group(n=180) p value 
Pre-PCI TMP blush, n(%) 0.420 
0 155(86.1) 156(86.7) 
1 4(2.2) 7(3.9) 
2 6(3.3) 2(1.1) 
3 15(8.3) 15(8.3) 
Post-PCI TMP blush, n(%) 0.643 
0 24(13.3) 26(14.4) 
1 37(20.6) 31(17.2) 
2 45(25.0) 39(21.7) 
3 74(41.1) 84(46.7) 
Procedure success, n(%) 165(91.7) 165(91.7) 1.000 
Stents per procedure 1.37±0.770 1.44±0.771 0.374 
AimRADIAL 2014 21
Table 2 Angiographic and procedural characteristics(3) 
MAC group(n=180) Control group(n=180) p value 
Aspiration catheter, n(%) 164(91.1) 159(88.3) 0.386 
GP IIb/IIIa, n(%) 
tirofiban use 97(53.9) 88(48.9) 0.343 
IABP support, n(%) 12(6.7) 10(5.6) 0.660 
Contrast (ml) 103±37 110±41 0.163 
Exchange guide catheter 
LCA 12(6.7) 11(6.1) 0.829 
RCA 1(0.6) 8(4.4) 0.018 
AimRADIAL 2014 22
Table 3 treatment times 
Time interval MAC group Control Group p 
prepare time(min) 4.6±1.4 4.7±1.5 0.802 
Cannulation time(min) 2.2±4.8 1.7±1.3 0.137 
Coronary time(min) 2.6±4.8 2.8±2.9 0.704 
Diagnostic time(min) 2.5±1.6 2.8±2.5 0.182 
Procedure time, CA(min) 7.4±4.3 7.2±4.7 0.896 
Procedure time, PCI(min) 24.8±10.7 28.7±12.0 0.003 
Total procedure time 32.1±15.4 35.9±12.9 0.013 
C2B(min) 17.1±5.5 19.2±5.6 <0.001 
D2B(min) 87.1±39.4 85.6±35.0 0. 732 
Fluorotime(min) 9.9±4.8 8.9±3.8 0.032 
AimRADIAL 2014 
23
time (min) 
15 
10 
5 
0 
Control group 
MAC group 
NS 
NS 
NS 
NS 
NS 
P=0.032 
AimRADIAL 2014 24
Control group 
MAC group 
50 
40 
30 
20 
10 
0 
Procedure time (min) 
P=0.003 
PCI Total 
C2B 
P=0.004 
P<0.001 
D2B 
150 
100 
50 
0 
NS 
AimRADIAL 2014 25
Table 4 Clinical Outcomes during 30 days and two-Year Follow-Up 
Variable MAC group (n=180) 
control 
group(n=180) 
P value 
The composite of MACE in 
hospital and 30-days, n(%) 
5(2.8) 4(2.2) 0.604 
Cardiac death 4(2.2) 4(2.2) 
Non-cardiac death 0 0 
Re-MI 1(0.6) 0 
TVR 1(0.6) 
Stent thrombosis 0 0 
Define 
1(0.6) 0 
probable 
The composite of MACE at 
24-months, n(%) 
14(7.8) 12(6.7) 0.839 
Cardiac death 6(3.3) 6(3.3) 
Non-cardiac death 4(2.2) 3(1.7) 
Re-MI 2(1.2) 1(0.6) 
TVR 1(0.6) 1(0.6) 
Stent thrombosis 1(0.6) 0 
Define 1(0.6) 1(0.6) 
Probable 0 0 
AimRADIAL 2014 
26
Percent survival 
months 
AimRADIAL 2014 
27
Take home message 
• A single transradial guiding catheter(MAC3.5 ) is 
feasible in a majority of patients with STEMI and had 
a shorter procedure time and fluoroscopic time . 
• A learning curve for using MAC 3.5 might be 
efficient . 
AimRADIAL 2014 28
Thanks for 
your attention! 
AimRADIAL 2014 
29

Weitere ähnliche Inhalte

Was ist angesagt?

Lessons learned from the history of CTO recanalization
Lessons learned from the history of CTO recanalizationLessons learned from the history of CTO recanalization
Lessons learned from the history of CTO recanalizationEuro CTO Club
 
14:35 Yamane - Update Japanese Multicenter Registry
14:35 Yamane -  Update Japanese Multicenter Registry14:35 Yamane -  Update Japanese Multicenter Registry
14:35 Yamane - Update Japanese Multicenter RegistryEuro CTO Club
 
17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO Recanilization17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO RecanilizationEuro CTO Club
 

Was ist angesagt? (20)

Bienert I - AIMRADIAL 2015 - Exposure
Bienert I - AIMRADIAL 2015 - ExposureBienert I - AIMRADIAL 2015 - Exposure
Bienert I - AIMRADIAL 2015 - Exposure
 
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stentingKedev S - AIMRADIAL 2014 Endovascular - Carotid stenting
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting
 
Sciahbasi A - AIMRADIAL 2015 - Hand grip test and transradial approach
Sciahbasi A - AIMRADIAL 2015 - Hand grip test and transradial approachSciahbasi A - AIMRADIAL 2015 - Hand grip test and transradial approach
Sciahbasi A - AIMRADIAL 2015 - Hand grip test and transradial approach
 
Valgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradialValgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradial
 
Bertrand OF - AIMRADIAL 2014 - Devices
Bertrand OF - AIMRADIAL 2014 - DevicesBertrand OF - AIMRADIAL 2014 - Devices
Bertrand OF - AIMRADIAL 2014 - Devices
 
Chugh S 201111
Chugh S 201111Chugh S 201111
Chugh S 201111
 
Jolly S - AIMRADIAL 2014 - Radiation protection
Jolly S - AIMRADIAL 2014 - Radiation protectionJolly S - AIMRADIAL 2014 - Radiation protection
Jolly S - AIMRADIAL 2014 - Radiation protection
 
Kanovsky J - AIMRADIAL 2014 - Radial artery remodeling
Kanovsky J - AIMRADIAL 2014 - Radial artery remodelingKanovsky J - AIMRADIAL 2014 - Radial artery remodeling
Kanovsky J - AIMRADIAL 2014 - Radial artery remodeling
 
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting developmentKedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
 
Devito FS - AIMRADIAL 2014 - Svelte Acrobat & 5Fr
Devito FS - AIMRADIAL 2014 - Svelte Acrobat & 5FrDevito FS - AIMRADIAL 2014 - Svelte Acrobat & 5Fr
Devito FS - AIMRADIAL 2014 - Svelte Acrobat & 5Fr
 
Gabric ID - AIMRADIAL 2014 - Primary PCI and left radial approach
Gabric ID - AIMRADIAL 2014 - Primary PCI and left radial approachGabric ID - AIMRADIAL 2014 - Primary PCI and left radial approach
Gabric ID - AIMRADIAL 2014 - Primary PCI and left radial approach
 
Bernat I - AIMRADIAL 2014 - Slender techniques in Europe
Bernat I - AIMRADIAL 2014 - Slender techniques in EuropeBernat I - AIMRADIAL 2014 - Slender techniques in Europe
Bernat I - AIMRADIAL 2014 - Slender techniques in Europe
 
Lessons learned from the history of CTO recanalization
Lessons learned from the history of CTO recanalizationLessons learned from the history of CTO recanalization
Lessons learned from the history of CTO recanalization
 
Cohen MG - AIMRADIAL 2014 Technical - Tortuosity
Cohen MG - AIMRADIAL 2014 Technical - TortuosityCohen MG - AIMRADIAL 2014 Technical - Tortuosity
Cohen MG - AIMRADIAL 2014 Technical - Tortuosity
 
14:35 Yamane - Update Japanese Multicenter Registry
14:35 Yamane -  Update Japanese Multicenter Registry14:35 Yamane -  Update Japanese Multicenter Registry
14:35 Yamane - Update Japanese Multicenter Registry
 
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolism
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolismPacchioni A - AIMRADIAL 2014 - Cerebral microembolism
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolism
 
17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO Recanilization17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO Recanilization
 
Saito S - AIMRADIAL 2013 - NAUSICA trial
Saito S - AIMRADIAL 2013 - NAUSICA trialSaito S - AIMRADIAL 2013 - NAUSICA trial
Saito S - AIMRADIAL 2013 - NAUSICA trial
 
Cohen MG - Transradial access - 201507
Cohen MG - Transradial access - 201507Cohen MG - Transradial access - 201507
Cohen MG - Transradial access - 201507
 
Speiser B - AIMRADIAL 2014 - Nursing workload
Speiser B - AIMRADIAL 2014 - Nursing workloadSpeiser B - AIMRADIAL 2014 - Nursing workload
Speiser B - AIMRADIAL 2014 - Nursing workload
 

Andere mochten auch

Guiding catheter in coronary intervention
Guiding catheter in coronary interventionGuiding catheter in coronary intervention
Guiding catheter in coronary interventionkefelegn Tadesse
 
Tools for transradial approach
Tools for transradial approachTools for transradial approach
Tools for transradial approachRamachandra Barik
 

Andere mochten auch (20)

Guiding catheter in coronary intervention
Guiding catheter in coronary interventionGuiding catheter in coronary intervention
Guiding catheter in coronary intervention
 
Kwan TW - AIMRADIAL 2014 Technical - Selection of catheters
Kwan TW - AIMRADIAL 2014 Technical - Selection of cathetersKwan TW - AIMRADIAL 2014 Technical - Selection of catheters
Kwan TW - AIMRADIAL 2014 Technical - Selection of catheters
 
Meerkin D
Meerkin DMeerkin D
Meerkin D
 
Tools for transradial approach
Tools for transradial approachTools for transradial approach
Tools for transradial approach
 
Dangoisse V - AIMRADIAL 2014 - Distal buddy in jail
Dangoisse V - AIMRADIAL 2014 - Distal buddy in jailDangoisse V - AIMRADIAL 2014 - Distal buddy in jail
Dangoisse V - AIMRADIAL 2014 - Distal buddy in jail
 
Louvard Y
Louvard YLouvard Y
Louvard Y
 
Stables R - AIMRADIAL 2015 - Bivalirudin and radial approach
Stables R - AIMRADIAL 2015 - Bivalirudin and radial approachStables R - AIMRADIAL 2015 - Bivalirudin and radial approach
Stables R - AIMRADIAL 2015 - Bivalirudin and radial approach
 
Speiser B - AIMRADIAL 2014 Technical - Patient preparation
Speiser B - AIMRADIAL 2014 Technical - Patient preparationSpeiser B - AIMRADIAL 2014 Technical - Patient preparation
Speiser B - AIMRADIAL 2014 Technical - Patient preparation
 
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMIKalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
 
Cohen MG 2016 Transradial primary PCI in shock
Cohen MG 2016 Transradial primary PCI in shockCohen MG 2016 Transradial primary PCI in shock
Cohen MG 2016 Transradial primary PCI in shock
 
Delewi R - AIMRADIAL 2015 - Radial artery occlusion
Delewi R - AIMRADIAL 2015 - Radial artery occlusionDelewi R - AIMRADIAL 2015 - Radial artery occlusion
Delewi R - AIMRADIAL 2015 - Radial artery occlusion
 
Meerkin D - AIMRADIAL 2014 - Structural disease
Meerkin D - AIMRADIAL 2014 - Structural diseaseMeerkin D - AIMRADIAL 2014 - Structural disease
Meerkin D - AIMRADIAL 2014 - Structural disease
 
Cohen MG - AIMRADIAL 2014 - Radial and TAVI
Cohen MG - AIMRADIAL 2014 - Radial and TAVICohen MG - AIMRADIAL 2014 - Radial and TAVI
Cohen MG - AIMRADIAL 2014 - Radial and TAVI
 
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervationPancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
 
Saito S DRAGON trial
Saito S DRAGON trialSaito S DRAGON trial
Saito S DRAGON trial
 
Mamas M - AIMRADIAL 2014 - Cardiogenic shock
Mamas M - AIMRADIAL 2014 - Cardiogenic shockMamas M - AIMRADIAL 2014 - Cardiogenic shock
Mamas M - AIMRADIAL 2014 - Cardiogenic shock
 
Tessitore E - AIMRADIAL 2014 - Sheathless
Tessitore E - AIMRADIAL 2014 - SheathlessTessitore E - AIMRADIAL 2014 - Sheathless
Tessitore E - AIMRADIAL 2014 - Sheathless
 
Edwards M - AIMRADIAL 2014 Endovascular - Amplatzer in visceral arteries
Edwards M - AIMRADIAL 2014 Endovascular - Amplatzer in visceral arteriesEdwards M - AIMRADIAL 2014 Endovascular - Amplatzer in visceral arteries
Edwards M - AIMRADIAL 2014 Endovascular - Amplatzer in visceral arteries
 
Ikari Y - AIMRADIAL 2015 - Carotid artery stenting
Ikari Y - AIMRADIAL 2015 - Carotid artery stentingIkari Y - AIMRADIAL 2015 - Carotid artery stenting
Ikari Y - AIMRADIAL 2015 - Carotid artery stenting
 
Cortese B - AIMRADIAL 2014 Endovascular - Iliac intervention
Cortese B - AIMRADIAL 2014 Endovascular - Iliac interventionCortese B - AIMRADIAL 2014 Endovascular - Iliac intervention
Cortese B - AIMRADIAL 2014 Endovascular - Iliac intervention
 

Ähnlich wie Guo J - AIMRADIAL 2014 - Single guiding catheter in STEMI

Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16Euro CTO Club
 
Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...
Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...
Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...Yamaguchi Yukihiro
 
PCI-CAMPOS-ACC14-Presentation-Slides.ppt
PCI-CAMPOS-ACC14-Presentation-Slides.pptPCI-CAMPOS-ACC14-Presentation-Slides.ppt
PCI-CAMPOS-ACC14-Presentation-Slides.pptThomasAMIK
 
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...Euro CTO Club
 
ga30102020son.pptx
ga30102020son.pptxga30102020son.pptx
ga30102020son.pptxgursel2
 
Percutanous PVL closure
Percutanous PVL closurePercutanous PVL closure
Percutanous PVL closureAhmedElBorae1
 
BT FFR .pptx
BT FFR .pptxBT FFR .pptx
BT FFR .pptxgursel2
 
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up dataFriday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up dataEuro CTO Club
 
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...Foro Epic
 
Advances in Imaging of ischaAemic stroke
Advances in Imaging of ischaAemic strokeAdvances in Imaging of ischaAemic stroke
Advances in Imaging of ischaAemic strokeDr Vipul Gupta
 

Ähnlich wie Guo J - AIMRADIAL 2014 - Single guiding catheter in STEMI (20)

Fu Q - AIMRADIAL 2014 - Left vs right radial approach
Fu Q - AIMRADIAL 2014 - Left vs right radial approachFu Q - AIMRADIAL 2014 - Left vs right radial approach
Fu Q - AIMRADIAL 2014 - Left vs right radial approach
 
Pancholy SB 2014
Pancholy SB 2014Pancholy SB 2014
Pancholy SB 2014
 
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
 
Cardoso C - AIMRADIAL 2014 - Radial operators and femoral
Cardoso C - AIMRADIAL 2014 - Radial operators and femoralCardoso C - AIMRADIAL 2014 - Radial operators and femoral
Cardoso C - AIMRADIAL 2014 - Radial operators and femoral
 
07 technical Staehli aimradial20170922 Catheters
07 technical Staehli aimradial20170922 Catheters07 technical Staehli aimradial20170922 Catheters
07 technical Staehli aimradial20170922 Catheters
 
06 aimradial2016 thu M Vorpahl
06 aimradial2016 thu M Vorpahl06 aimradial2016 thu M Vorpahl
06 aimradial2016 thu M Vorpahl
 
06 Olivecrona aimradial20170922 Radial CTO
06 Olivecrona aimradial20170922 Radial CTO06 Olivecrona aimradial20170922 Radial CTO
06 Olivecrona aimradial20170922 Radial CTO
 
Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...
Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...
Successful Two-Staged PCI for Double Chronic Total Occlusions of the Ostial L...
 
PCI-CAMPOS-ACC14-Presentation-Slides.ppt
PCI-CAMPOS-ACC14-Presentation-Slides.pptPCI-CAMPOS-ACC14-Presentation-Slides.ppt
PCI-CAMPOS-ACC14-Presentation-Slides.ppt
 
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
 
ga30102020son.pptx
ga30102020son.pptxga30102020son.pptx
ga30102020son.pptx
 
Percutanous PVL closure
Percutanous PVL closurePercutanous PVL closure
Percutanous PVL closure
 
Ikari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABPIkari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABP
 
BT FFR .pptx
BT FFR .pptxBT FFR .pptx
BT FFR .pptx
 
Da Silva RL - AIMRADIAL 2015 - Spasmolytic
Da Silva RL - AIMRADIAL 2015 - SpasmolyticDa Silva RL - AIMRADIAL 2015 - Spasmolytic
Da Silva RL - AIMRADIAL 2015 - Spasmolytic
 
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up dataFriday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
 
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
 
Kandzari DE 201305
Kandzari DE 201305Kandzari DE 201305
Kandzari DE 201305
 
Advances in Imaging of ischaAemic stroke
Advances in Imaging of ischaAemic strokeAdvances in Imaging of ischaAemic stroke
Advances in Imaging of ischaAemic stroke
 
E-poster13 Rusza aimradial20170922 Hybrid approach
E-poster13 Rusza aimradial20170922 Hybrid approachE-poster13 Rusza aimradial20170922 Hybrid approach
E-poster13 Rusza aimradial20170922 Hybrid approach
 

Mehr von International Chair on Interventional Cardiology and Transradial Approach

Mehr von International Chair on Interventional Cardiology and Transradial Approach (20)

PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
 
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses GalazPCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
 
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
 
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
 
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo BernatPCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
 
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán RuzsaPCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
 
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
 
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
 
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
 
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim NolanPCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
 
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
 
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C GilchristPCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
 
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C GilchristPCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
 
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. BertrandPCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
 
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
 
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
 
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
 
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. FearonPCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
 
PCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin BerryPCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin Berry
 
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
 

Kürzlich hochgeladen

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 

Kürzlich hochgeladen (20)

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 

Guo J - AIMRADIAL 2014 - Single guiding catheter in STEMI

  • 1. Department of Cardiology, Luhe hospital,Capital Medical University Jincheng Guo AimRADIAL 2014 1
  • 2. Disclosure • Research grant The capital health research and development of special 2011-7071-01 AimRADIAL 2014 2
  • 3. Background 15 45 75 105 135 165 195 225 15 12 9 6 3 0 Mortality (%) Door to balloon time (minutes) BMJ 2009;338:b1807 AimRADIAL 2014 3
  • 4. Background • Several strategies to improve D2B times prior to catheterization laboratory (cath lab) arrival. • Few recommendations in the cath lab, cath lab to balloon(C2B) times. • Transradial vs transfemoral improved clinical outcomes. • longer C2B times and fluoroscopic times for transradial approach AimRADIAL 2014 4
  • 5. Background Trasnradial Strategies For Primary PCI In Cathlab patients with STEMI Radial access NIRA NIRA Primary PCI IRA GC? GC IRA Diganostic MP JL/R NIRA+IRA IRA:infarct-related artery; NIRA:non-infarct-related artery; GC: guiding catheter L: JL R: JR MP: multipurpose ECG-Guided CA 5 AimRADIAL 2014
  • 6. What is the optimal guiding catheter for “a single catheter technique” Author year Journal Guiding cather study Sample Youssef AA, et al 2008 Eurointervention Ikari left (IL) 3.5 Prospective observational 621 Roberts EB, et al 2011 J Interv Cardiol Q guide atheter observational 57 Chow J, et al 2012 J Interv Cardiol Ikari left retrospective study 362 Moon KW, et al 2012 J Interv Cardiol 6 Fr RM® 3.5 retrospective study 31 Malaiapan Y , et al 2013 Cardiovasc Revasc Med Kimny matched cohort 106 AimRADIAL 2014 6
  • 7. What is the ideal single guide catheter? Q Curve Ikari left (IL) kimny AimRADIAL 2014 7
  • 8. What is the ideal single guide catheter for us? MAC guide catheter AimRADIAL 2014 8
  • 9. MAC3.5 guiding catheter for LCA AimRADIAL 2014 9
  • 10. Manipulation of the MAC guiding catheter for LCA Natural position U shape curve Push/ Counterclockwise pull clockwise AimRADIAL 2014 10
  • 11. Manipulation of the MAC guiding catheter for RCA clockwise Push and U shape form Engage and pull AimRADIAL 2014 11
  • 12. To investigate the safety and feasibilityof using a single guiding catheter (MAC 3.5) for left and right coronary angiography and intervention in patients with STEMI Objective AimRADIAL 2014 12
  • 13. Inclusion Criteria • symptom onset within 12 hours before admission • candidate for primary PCI • no contraindications to antiplatelet and anticoagulant therapy • lesions of native coronary artery. Exclusion Criteria No radial pulse palpable Throm bolytic therapy AimRADIAL 2014 13
  • 14. Definitions of times and intervals Time/interval Source/Definition Cathlab arrival time Time that the patient was placed on the cathlab table Prepare time Time from cath lab table to local anesthesia Cannulation time time from local anesthesia to sheath insertion Coronary time time from sheath insertion to first cineangiography recording Time/Definitions interval of times and intervals Source/Definition Cathlab Cath lab=Catheterization arrival time lab, CA=coronary Time that angiography; the patient PCI=was percutaneous placed on the coronary cathlab intervention table Prepare time Time from cath lab table to local anesthesia Cannulation time time from local anesthesia to sheath insertion Coronary time time from sheath insertion to first cineangiography recording Diagnostic time first cineangiography recording to completion of the last angiographic Diagnostic time first cineangiography recording to completion of the last angiographic cine acquisition procedure time,CA Cannulation time+ coronary time+ diagnostic time cine acquisition procedure time,PCI Time from the end of diagnostic time to the end of PCI procedure time,CA Cannulation time+ coronary time+ diagnostic time procedure time,PCI Time from the end of diagnostic time to the end of PCI Total procedure time Including CA and PCI procedure time Cath lab door to balloon time(C2B) Total procedure time Including CA and PCI procedure time Interval between the Cath lab arrival time and the first device was activated to open the artery regardless of the type of device used. Interval between the Cath lab arrival time and the first device was activated to open the artery regardless of the type of device used. Cath lab door to balloon time(C2B) Door to balloon time(D2B) Interval from initial presentation to cathlab arrive time+C2B Door to balloon time(D2B) Interval from initial presentation to cathlab arrive time+C2B Cath lab=Catheterization lab, CA=coronary angiography; PCI=percutaneous coronary intervention AimRADIAL 2014 14
  • 15. Design • DESIGN: Prospective, randomized (1:1), parallel group, Single-center trial. MAC group—MAC for left and right Coronary angiography an intervention Control group--first underwent coronary angiography with diagnostic Tiger catheter followed by guiding catheter selection for intervention 360 patients enrolled between September 2011 and Dec 2013 in our center MAC group (N=180) Control Group (N=180) Crossover to Femoral 6 9 MAC group (N=180) Control Group (N=180) cathlab door to balloon time Procedure time, fluoroscopic time,Door to balloon time, MACE at 2 years Intention-to-treat analysis AimRADIAL 2014 15
  • 16. Primay PCI protocol access sheath Coronary angiogarphy Right raidal Catheter Tiger MAC3.5 NIRA IRA RCA 2 projections LCA 5 projections RCA 1 projections LCA LAO+cranial Cranial+caudal LAO45 AP cra+cau Wire Hytrophilic Long Long Hytrophilic 2 projections anticoagulation heparin AimRADIAL 2014 16
  • 17. Table 1 baseline characteristics MAC group(n=180) Control group(n=180) p value age 63.23±12.07 62.47±12.25 0.702 male/female 135/45 136/44 0.903 Cardiovascular risk factors diabetes mellitus, n(%) 50(27.8) 56(31.1) 0.488 hypertension, n(%) 74(41.1) 68(37.8) 0.458 hypercholesterolaemia, n(%) 61(33.9) 56(31.3) 0.574 Present smoking, n(%) 106(58.9) 96(53.3) 0.288 history of CAD, n(%) 18 (10.0) 26(14.4) 0.198 history of stroke, n(%) 19 (10.6) 23(12.8) 0.511 Previous MI, n(%) 5(2.8) 5(2.8) 1.000 Previous renal insufficiency, n(%) 5(2.8) 6(3.3) 0.752 Previous PCI, n(%) 11(6.1) 9(5.0) 0.636 Killip class on admission, n(%) 0.410 I~ II 165(91.7) 161(89.4) III~ IV 15(8.03 19(10.6) AimRADIAL 2014 17
  • 18. Coronary angiography success rate MAC 3.5 LCA(180) RCA(180) Failure(6) success(174) Failure(1) success(179) success(1) Tiger LCA(180) RCA(180) Failure(4) success(176) Failure(3) success(177) Tiger JL4.0 success(5) = = Tiger/AL2.0 JL4.0/4.5 MAC3.5 GC JL4.0 success(1) success(1) success(2) = = = AL1.0 JR4.0 success(1) success(1) success(1) = = = = success(1) SAL1.0 JR3.5 GC AimRADIAL 2014 18
  • 19. Table 2 Angiographic and procedural characteristics(1) MAC group (n=180) Control group (n=180) p value Target vessel, n(%) 0.070 Left main 1(0.6) 0(0) LAD 76(42.2) 97(53.9) LCX 26(14.4) 15(8.3) RCA 77(42.8) 68(37.8) Disease vessles,n(%) 0.270 single 59(32.8) 73(40.6) double 63(35.0) 52(28.9) triple 58(32.2) 55(30.6) AimRADIAL 2014 19
  • 20. Table 2 Angiographic and procedural characteristics(2) MAC group(n=180) Control group(n=180) p value Access site crossover 6(3.3) 9(5.0) 0.428 Guiding catheter exchange 13(9.72) 19(9.86) 0.266 Pre-PCI TIMI flow, n(%) 0.354 0/1 146(81.1) 151(83.9) 2 10(5.6) 13(7.2) 3 24(13.3) 16(8.9) Post-PCI TIMI flow, n(%) 0.704 0/1 8(4.4) 9(5.0) 2 15(8.3) 11(6.1) 3 157(87.2) 160(88.9) CTFC ,frames Pre-PCI 89.4±23.3 90.5±22.3 0.548 Post-PCI 31.6±20.9 30.2±21.5 0.518 AimRADIAL 2014 20
  • 21. Table 2 Angiographic and procedural characteristics(2) MAC group(n=180) Control group(n=180) p value Pre-PCI TMP blush, n(%) 0.420 0 155(86.1) 156(86.7) 1 4(2.2) 7(3.9) 2 6(3.3) 2(1.1) 3 15(8.3) 15(8.3) Post-PCI TMP blush, n(%) 0.643 0 24(13.3) 26(14.4) 1 37(20.6) 31(17.2) 2 45(25.0) 39(21.7) 3 74(41.1) 84(46.7) Procedure success, n(%) 165(91.7) 165(91.7) 1.000 Stents per procedure 1.37±0.770 1.44±0.771 0.374 AimRADIAL 2014 21
  • 22. Table 2 Angiographic and procedural characteristics(3) MAC group(n=180) Control group(n=180) p value Aspiration catheter, n(%) 164(91.1) 159(88.3) 0.386 GP IIb/IIIa, n(%) tirofiban use 97(53.9) 88(48.9) 0.343 IABP support, n(%) 12(6.7) 10(5.6) 0.660 Contrast (ml) 103±37 110±41 0.163 Exchange guide catheter LCA 12(6.7) 11(6.1) 0.829 RCA 1(0.6) 8(4.4) 0.018 AimRADIAL 2014 22
  • 23. Table 3 treatment times Time interval MAC group Control Group p prepare time(min) 4.6±1.4 4.7±1.5 0.802 Cannulation time(min) 2.2±4.8 1.7±1.3 0.137 Coronary time(min) 2.6±4.8 2.8±2.9 0.704 Diagnostic time(min) 2.5±1.6 2.8±2.5 0.182 Procedure time, CA(min) 7.4±4.3 7.2±4.7 0.896 Procedure time, PCI(min) 24.8±10.7 28.7±12.0 0.003 Total procedure time 32.1±15.4 35.9±12.9 0.013 C2B(min) 17.1±5.5 19.2±5.6 <0.001 D2B(min) 87.1±39.4 85.6±35.0 0. 732 Fluorotime(min) 9.9±4.8 8.9±3.8 0.032 AimRADIAL 2014 23
  • 24. time (min) 15 10 5 0 Control group MAC group NS NS NS NS NS P=0.032 AimRADIAL 2014 24
  • 25. Control group MAC group 50 40 30 20 10 0 Procedure time (min) P=0.003 PCI Total C2B P=0.004 P<0.001 D2B 150 100 50 0 NS AimRADIAL 2014 25
  • 26. Table 4 Clinical Outcomes during 30 days and two-Year Follow-Up Variable MAC group (n=180) control group(n=180) P value The composite of MACE in hospital and 30-days, n(%) 5(2.8) 4(2.2) 0.604 Cardiac death 4(2.2) 4(2.2) Non-cardiac death 0 0 Re-MI 1(0.6) 0 TVR 1(0.6) Stent thrombosis 0 0 Define 1(0.6) 0 probable The composite of MACE at 24-months, n(%) 14(7.8) 12(6.7) 0.839 Cardiac death 6(3.3) 6(3.3) Non-cardiac death 4(2.2) 3(1.7) Re-MI 2(1.2) 1(0.6) TVR 1(0.6) 1(0.6) Stent thrombosis 1(0.6) 0 Define 1(0.6) 1(0.6) Probable 0 0 AimRADIAL 2014 26
  • 27. Percent survival months AimRADIAL 2014 27
  • 28. Take home message • A single transradial guiding catheter(MAC3.5 ) is feasible in a majority of patients with STEMI and had a shorter procedure time and fluoroscopic time . • A learning curve for using MAC 3.5 might be efficient . AimRADIAL 2014 28
  • 29. Thanks for your attention! AimRADIAL 2014 29